Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia
Open accessThe DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index.
Abstract
Prediabetes can be defined by the presence of impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT), or glycated haemoglobin (HbA1c) to identify individuals at increased risk of developing type 2 diabetes (T2D). The World Health Organization (WHO, 1999) and the American Diabetes Association (ADA, 2003) utilise different cut-off values for IFG (WHO: 6.1–6.9 mmol/L; ADA: 5.6–6.9 mmol/L) but the same cut-off values for IGT (7.8–11.0 mmol/L). This review investigates whether there are differences in prevalence of IFG, IGT, and combined IFG&IGT between ethnicities, in particular Asian Chinese and European Caucasians. In total, we identified 19 studies using the WHO1999 classification, for which the average proportional prevalence for isolated (i)-IFG, i-IGT, and combined IFG&IGT were 43.9%, 41.0%, and 13.5%, respectively, for Caucasian and 29.2%, 49.4%, and 18.2%, respectively, for Asian. For the 14 studies using ADA2003 classification, the average proportional i-IFG, i-IGT, and combined IFG&IGT prevalences were 58.0%, 20.3%, and 19.8%, respectively, for Caucasian; 48.1%, 27.7%, and 20.5%, respectively, for Asian. Whilst not statistically different, there may be clinically relevant differences in the two populations, with our observations for both classifications indicating that prevalence of i-IFG is higher in Caucasian cohorts whilst i-IGT and combined IFG&IGT are both higher in Asian cohorts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Proposed hypothesis of lipid overspill from subcutaneous adipose into ectopic sites leading to insulin resistance and type 2 diabetes (T2D) [14].](https://figures.cochat.ai/paper-figures/bef9706d56e5432096261f7eb3f78eb8/prevalence-of-pre-diabetes-across-ethnicities-a-review-of-impaired-fasting-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As in normal conditions (i.e., no insulin resistance), blood glucose should return to normal levels during the 2 h after ingestion [95,96].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · cited 3×
“Publication bias was assessed by the Begg-Mazumdar [82] and Egger et al.”
MethodInfluentialLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216 · cited 1×
“Although perceived to be a disease plaguing the more developed nations, such as the countries of Western Europe, North America, and Oceania, T2D prevalence rates have recently been reported to be escalating in developing Asian countries [1], in particular, China [5–8], and it is estimated that rates will reach 69% by…”
BackgroundDiagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 2×
“Decreased insulin secretion and concomitant increased blood glucose levels consequently also lead to the reduced uptake of glucose by skeletal muscle, thereby enhancing muscle insulin resistance [27].”
Background
Research works printed but not linked: 1
- Dong, 2003, The prevalence of diabetes and the risk factor in Chinese population in Qingdao city. 18th International Diabetes Federation Congress, Paris, France, 24–29 August 2003, Diabetes Metab., 29, 4S21
Cited by
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
“In accordance with the higher prevalence of diabetes in South Asian ethnicity, the Asian population indeed showed a higher prevalence in pre-diabetes than the Western population [40].”
ResultGlobal epidemiology of prediabetes - present and future perspectives
Hostalek, U. (2019) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-019-0080-0 · Cited by 381
“A number of epidemiological studies have demonstrated a clear relationship between ethnicity and likelihood of prediabetes; African American, Native American, South Asian and Hispanic have all been shown to have an increased risk of having prediabetes compared with their Caucasian counterparts [14, 24].”
BackgroundMethodDiabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
Won, J. C., Lee, J. H., Kim, J. H., Kang, E. S., Won, K. C., Kim, D. J., & Lee, M.-K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0017 · Cited by 299
Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
Jung, C.-H., Son, J. W., Kang, S., Kim, W. J., Kim, H.-S., Kim, H. S., Seo, M., Shin, H.-J., Lee, S.-S., Jeong, S. J., et al. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0254 · Cited by 223
“Prevalence estimates of IFG reported in the literature vary greatly due to the diagnostic criteria used, the screening test, and characteristics of the study population [26-28].”
BackgroundInterventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis
Galaviz, K. I., Weber, M. B., Suvada, K., Gujral, U. P., Wei, J., Merchant, R., Dharanendra, S., Haw, J. S., Narayan, K. M. V., & Ali, M. K. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.10.020 · Cited by 149
Insights and implications of sexual dimorphism in osteoporosis
Zhang, Y., Xie, N., Sun, X., Nice, E. C., Liou, Y., Huang, C., Zhu, H., & Shen, Z. (2024) · Bone Research · doi:10.1038/s41413-023-00306-4 · Cited by 184
“315 In China, it has been reported that the overall prevalence of total diabetes was 12.8%, ranging from 6.2% in Guizhou to as high as 19.9% in Inner Mongolia, and a higher prevalence was observed in men than in women.”
BackgroundInfluentialAnthocyanins-gut microbiota-health axis: A review
Liang, A., Leonard, W., Beasley, J. T., Fang, Z., Zhang, P., & Ranadheera, C. S. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2187212 · Cited by 157
“Fasting glucose value represents how body manages plasma glucose after overnight fast, while postprandial blood glucose indicates the glycaemic response after meal (Yip et al. 2017).”
The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis
Che, T., Yan, C., Tian, D., Zhang, X., Liu, X., & Wu, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773646 · Cited by 117
“However, many patients with impaired blood glucose present with normal fasting blood glucose and elevated postprandial blood glucose (31).”
BackgroundBenefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype
Campbell, M. D., Sathish, T., Zimmet, P., Thankappan, K. R., Oldenburg, B. F., Owens, D. R., Shaw, J. E., & Tapp, R. J. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0316-1 · Cited by 135
Trouwborst, I., Bowser, S. M., Goossens, G. H., & Blaak, E. E. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00077 · Cited by 111
Kristian, R. E. T. T., & Gottwald‐Hostalek, U. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1601455 · Cited by 137
Ramírez‐Vélez, R., Pérez-Sousa, M. Á., González‐Ruíz, K., Cano, C. A., Schmidt‐RioValle, J., Correa‐Rodríguez, M., Izquierdo, M., Romero-García, J. A., Rodríguez, A. Y. C., Triana-Reina, H. R., et al. (2019) · Nutrients · doi:10.3390/nu11112654 · Cited by 124
“While available guidelines for T2DM prevention and treatment show that both old age (60 years or more) and prediabetes are important risk factors for diabetes [9,13], a comprehensive consensus has yet not been reached on the best indices for evaluating the status and risk of prediabetes in the elderly Latino populatio…”
BackgroundEskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
Khalili, D., Khayamzadeh, M., Kohansal, K., Ahanchi, N. S., Hasheminia, M., Hadaegh, F., Tohidi, M., Azizi, F., & Habibi-Moeini, A. S. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01291-9 · Cited by 123
Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes
Jiang, C., Yang, R., Kuang, M., Meng, Y., Zhong, M., & Zou, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01594-7 · Cited by 99
“Some limitations need to be emphasized in this study: (1) The diagnostic criteria for pre-diabetes in this study were based on IFG; however, in the Asian population, the use of isolated IFG for pre-diabetes appears to result in a lower prevalence [46].”
BackgroundShirinzadeh, M., Afshin-Pour, B., Angeles, R., Gaber, J., & Agarwal, G. (2019) · Globalization and Health · doi:10.1186/s12992-019-0451-4 · Cited by 72
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 85
Sathish, T., Khunti, K., Narayan, K. M. V., Mohan, V., Davies, M. J., Yates, T., Oldenburg, B., Thankappan, K. R., Tapp, R. J., Bajpai, R., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0696 · Cited by 67
Yu, H., Ho, M. M., Liu, X., Yang, J., Chau, P. H., & Fong, D. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01096-1 · Cited by 80
Huang, L., Fang, Y., & Tang, L. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00846-y · Cited by 74
Proteomic signatures for identification of impaired glucose tolerance
Carrasco-Zanini, J., Pietzner, M., Lindbohm, J. V., Wheeler, E., Oerton, E., Kerrison, N., Simpson, M., Westacott, M., Drolet, D., Kivimaki, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02055-z · Cited by 52
Golovaty, I., Ritchie, N. D., Tuomilehto, J. O., Mohan, V., Ali, M. K., Gregg, E. W., Bergman, M., & Moin, T. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110195 · Cited by 59
Jiang, Z.-Z., Zhu, J., Shen, H., Zhao, S., Tang, Y., Shao-qi, T., Liu, X., & Jiang, T.-A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.832491 · Cited by 44
“However, few studies about the arteriosclerosis in these populations are available, which may hinder the identification of who should be fast-tracked into a prevention programmer during the early stage of diabetes (24).”
BackgroundIslam, Z., Akter, S., Inoue, Y., Hu, H., Kuwahara, K., Nakagawa, T., Honda, T., Yamamoto, S., Okazaki, H., Miyamoto, T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1213 · Cited by 53
“Covariates included age, sex, worksite, BMI, smoking, hypertension, and dyslipidemia.”
BackgroundInfluentialJiang, L., Li, L., Xu, Z., Tang, Y. R., Zhai, Y., Fu, X., Liu, D., & Wu, Q. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1360874 · Cited by 50
Koh, H., Moh, A. M. C., Yeoh, E. C. K., Lin, Y., Low, S. K. M., Ooi, S. T., Tan, S. K., Lin, J. H. X., & Hoong, C. W. S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26837 · Cited by 43
Rising trends of diabetes in South Asia: A systematic review and meta-analysis
Ranasinghe, P. D., Rathnayake, N., Wijayawardhana, S., Jeyapragasam, H., Meegoda, V. J., Jayawardena, R., & Misra, A. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103160 · Cited by 64
Tura, A., Pacini, G., Moro, E., Vrbíková, J., Bendlová, B., & Kautzky‐Willer, A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.019 · Cited by 44
Hu, H., Kawasaki, Y., Kuwahara, K., Nakagawa, T., Honda, T., Yamamoto, S., Eguchi, M., Kochi, T., Nishihara, A., Imai, T., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.12.023 · Cited by 40
Chakkalakal, R. J., Galaviz, K. I., Thirunavukkarasu, S., Shah, M. K., & Narayan, K. M. V. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-060222-023417 · Cited by 35
Stress and the CRH System, Norepinephrine, Depression, and Type 2 Diabetes
Perrelli, M., Goparaju, P., Postolache, T. T., del Bosque‐Plata, L., & Gragnoli, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061187 · Cited by 40
“Meanwhile, worldwide, about 10% of adults suffer from T2D [3], with 58% of European Caucasians having impaired fasting glucose (glycemia ≥ 100 mg/dL) [4].”
BackgroundDany, F., Dewi, R. M., Tjandrarini, D. H., Pradono, J., Delima, D., Sariadji, K., Handayani, S., & Kusumawardani, N. (2020) · BMC Public Health · doi:10.1186/s12889-020-09592-7 · Cited by 47
Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
Chan, J. C. N., Yang, A., Chu, N. H. S., & Chow, E. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15700 · Cited by 38
“153,154 In the DECODE study, there was an independent relationship between FPG and mortality only when FPG was more than 7.0 mmol/L, 154 while the relationship between i-IGT and CVD or all-cause mortality was continuous.”
InfluentialIdentification of Education Models to Improve Health Outcomes in Arab Women with Pre-Diabetes
Al-Hamdan, R., Avery, A., Salter, A., Al-Disi, D., Al-Daghri, N. M., & McCullough, F. (2019) · Nutrients · doi:10.3390/nu11051113 · Cited by 30
Li, X., Li, Y., Liang, Y., Hu, R., Xu, W., & Liu, Y. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0209 · Cited by 33
Chai, Y., Liu, Y., Yang, R., Kuang, M., Qiu, J., & Zou, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13783 · Cited by 33
Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study
Roncero‐Ramos, I., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., Gómez-Delgado, F., Jiménez-Lucena, R., García‐Ríos, A., Vals‐Delgado, C., Romero-Baldonado, C., Luque, R. M., Ordovás, J. M., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.027 · Cited by 39
Zhang, X., Yue, Y., Liu, S., Cong, X., Wang, W., & Li, J. (2023) · BMC Public Health · doi:10.1186/s12889-022-14912-0 · Cited by 31
“A review investigated whether there were differences in the prevalence of prediabetes phenotype among different ethnic groups and concluded that the prevalence of IGT is higher in Asian populations [15].”
BackgroundRestrepo, B. I., Kleynhans, L., Salinas, A. B., Abdelbary, B. E., Tshivhula, H., Aguillón-Durán, G. P., Kunsevi-Kilola, C., Salinas, G., Stanley, K., Malherbe, S. T., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.007 · Cited by 26
“This is known to vary between ethnicities [28].”
BackgroundRuiz‐Pozo, V. A., Guevara‐Ramírez, P., Paz‐Cruz, E., Tamayo‐Trujillo, R., Cadena-Ullauri, S., Frías-Toral, E., Simancas‐Racines, D., Roshkova, Y. V. A., Reytor-González, C., & Zambrano, A. K. (2024) · Food and Agricultural Immunology · doi:10.1080/09540105.2024.2398042 · Cited by 30
Bean, C. N., Dineen, T. E., & Jung, M. E. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.09.001 · Cited by 28
Song, T., Fu, Y., Wang, Y., Li, W., Zhao, J., Wang, X., Wang, H., Zhao, Y., & Fu, X. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01839-w · Cited by 28
“Interestingly, the correlation of FGF-23 with diabetes was not observed, which might be explained by: (1) According to the results in our study, FGF-23 was correlated with increased FBG in CHD patients and higher FBG was considered as a risk factor for pre-diabetes [27], FGF-23 might be correlated with the existence o…”
ResultType 2 Diabetes Mellitus in Childhood and Adolescence
Koren, D., & Levitsky, L. L. (2021) · Pediatrics in Review · doi:10.1542/pir.2019-0236 · Cited by 25
Palmatine ameliorates high fat diet induced impaired glucose tolerance
Tian, X., Zhang, Y., Li, H., Li, Y., Wang, N., Zhang, W., & Boyan, M. (2020) · Biological Research · doi:10.1186/s40659-020-00308-0 · Cited by 23
Ntzouvani, A., Antonopoulou, S., & Nomikos, T. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001338 · Cited by 23
“WHO or American Diabetes Association criteria(22,23)); (3) Type of intervention and control: Studies comparing the effects of a diet containing nuts or seeds (whole or ground/ milled) against a diet without nuts or seeds were considered eligible.”
BackgroundThe Natural Course of Impaired Fasting Glucose
Święcicka-Klama, A., Połtyn–Zaradna, K., Szuba, A., & Zatońska, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_571 · Cited by 23
PM2.5 promotes β cell damage by increasing inflammatory factors in mice with streptozotocin
Zhang, B., Yin, R., Lang, J., Yang, L., Zhao, D., & Ma, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10264 · Cited by 19
“Both WHO1999 and ADA2003 recommend cut points for IGT as 7.8-11.0 mmol/l measured at the 2 h time point of an OGTT (28).”
BackgroundInfluentialPeng, M. Q., Karvonen-Gutierrez, C. A., Herman, W. H., Mukherjee, B., & Park, S. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad033 · Cited by 25
Mkrtumyan, A. M., As, A., Demidova, T. Y., Volkova, A. R., Dudinskaya, Е. N., Vertkin, A., & Vorobiev, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051390 · Cited by 20
“2% according to World Health Organization (WHO) and American Diabetes Association (ADA) data, respectively [1,5,7].”
BackgroundInfluentialAhn, E. M., Asamenew, G., Kim, H. W., Lee, S. H., Yoo, S.-M., Cho, S., Cha, Y., & Kang, M. (2020) · Nutrients · doi:10.3390/nu12051261 · Cited by 19
“Obesity is a state of low-grade, chronic inflammation and a major cause of insulin resistance that gives rise to type 2 diabetes [1,2].”
BackgroundMuthu, M., & Nordström, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061385 · Cited by 20
“8 and 11 mmol/L the person is considered to have impaired glucose tolerance and should be further diagnosed; and above 11 mmol/L the person is considered to be diabetic [40].”
BackgroundWang, X., Huang, C., Liu, Y., Han, Y. Y., & Hu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965545 · Cited by 17
Hypoglycemic Effect of Polysaccharides from Physalis alkekengi L. in Type 2 Diabetes Mellitus Mice
Zhang, Y., Wang, M., Li, P., Lv, G., Yao, J., & Zhao, L. G. (2024) · Biology · doi:10.3390/biology13070496 · Cited by 16
“The glucose tolerance of each group of mice was assessed by measuring the changes 8 Previous studies have demonstrated that there is a close relationship between fasting blood glucose levels and glucose tolerance [30].”
BackgroundMethodHyperglycemia attenuates the association between telomere length and age in Ukrainian population
Krasnienkov, D. S., Khalangot, M. D., Kravchenko, V. I., Kovtun, V. A., Gurianov, V. G., Chizhova, V. P., Korkushko, O. V., Shatylo, V. B., Kukharsky, V. M., & Vaiserman, A. M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.06.027 · Cited by 16
“6mmol/L] (Yip et al., 2017), both these cut-off values were used in evaluating the results of the FPG test.”
Strachan, S. M., Bean, C. N., & Jung, M. E. (2018) · Health & Social Care in the Community · doi:10.1111/hsc.12628 · Cited by 23
Sathish, T., Tapp, R. J., & Shaw, J. E. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14529 · Cited by 15
“58% of Caucasians and 29%-48% of Asians, depending on the criteria).(3) The proportional prevalence of isolated IFG (ADA criteria) is much larger in certain other ethnic groups; 84% in Asian Indians, for example.”
BackgroundPramono, A., Fitranti, D. Y., Nugroho, K. H., Sobirin, M. A., & Syauqy, A. (2023) · Journal of Obesity · doi:10.1155/2023/2885769 · Cited by 13
Educational Model and Prevention on Prediabetes: A Systematic Review
Amelia, R., Harahap, J., Zulham, Z., Fujiati, I. I., & Wijaya, H. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998275518231006074504 · Cited by 15
“Otherwise, the prevalence of isolated IGT and combining both IFG and IGT is higher in Asians [11].”
BackgroundLiu, Z., Yang, Y., Xu, Y., Zhang, Z., Tang, R., Liu, J., Jiang, H., & Zhao, R. (2024) · Food & Function · doi:10.1039/d4fo02805h · Cited by 13
Kausar, M. A., Shahid, S., Anwar, S., Kuddus, M., Khan, M. K. A., Khalifa, A. M., Khatoon, F., Alotaibi, A. D., Alkhodairy, S. F., Snoussi, M., et al. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.5.3 · Cited by 16
Distinct Roles for Brain and Pancreas in Basal and Postprandial Glucose Homeostasis
Alonge, K. M., Porte, D., & Schwartz, M. W. (2023) · Diabetes · doi:10.2337/db22-0969 · Cited by 16
Hypoglycaemic effect of catalpol in a mouse model of high-fat diet-induced prediabetes
Xu, D., Huang, X., Hassan, H. M., Wang, L., Li, S., Jiang, Z., Zhang, L., & Wang, T. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0075 · Cited by 14
“Insulin triggers the translocation of GLUT4 from intracellular stores to the plasma membrane in skeletal muscle, followed by its transport into the sarcolemma to promote glucose uptake into myocytes (Gao et al. 2017; Yip, Sequeira et al. 2017).”
BackgroundJung, J. Y., Ryoo, J., Chung, P., Oh, C., Choi, J., & Park, S. K. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01290-0 · Cited by 14
Zhan, X., Wang, L., Wang, Z., Chai, S., Zhu, X., Ren, W., & Chang, X. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-81 · Cited by 15
Fachim, H., Siddals, K. W., Malipatil, N. S., Donn, R. P., Moreno, G. Y., Dalton, C., Adam, S., Soran, H., Gibson, M., & Heald, A. H. (2020) · Adipocyte · doi:10.1080/21623945.2020.1732513 · Cited by 10
Family Involvement to Stop the Conversion of Prediabetes to Diabetes
Prakoso, D. A., Mahendradhata, Y., & Istiono, W. (2023) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0019 · Cited by 11
Conceptual Overview of Prevalence of Prediabetes
Monika, Arora, P., Kumar, V., & Popli, P. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998285294240307052909 · Cited by 12
Siddiqui, S., Zainal, H., Harun, S. N., & Ghadzi, S. M. S. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.10.002 · Cited by 11
Zhu, W., Shi, P., Fu, J., Liang, A., Zheng, T., Wu, X., & Yuan, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01752-5 · Cited by 12
Low-calorie diets for people with isolated impaired fasting glucose
Sathish, T., Taylor, R., Khunti, K., Tapp, R. J., Raben, A., Zhu, R., Kapoor, N., Narayan, K. M. V., Ali, M. K., & Shaw, J. E. (2024) · Communications Medicine · doi:10.1038/s43856-024-00466-2 · Cited by 10
Mathews, E., Sathish, T., Joseph, A., Kodapally, B., Thulaseedharan, J. V., Narayan, K. V., Oldenburg, B. F., & Thankappan, K. R. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17631.1 · Cited by 9
Li, T., Cao, C., Xuan, X., Liu, W., Xiao, X., & Wei, C. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01518-9 · Cited by 9
“Finally, in this study, pre-diabetes was only recognized by the researchers in the subjects with impaired fasting glucose levels, which could have resulted in a missed diagnosis [62].”
BackgroundZhu, R., Jalo, E., Silvestre, M. P., Poppitt, S. D., Handjieva‐Darlenska, T., Handjiev, S., Huttunen‐Lenz, M., Mackintosh, K. A., Stratton, G., Navas‐Carretero, S., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0549 · Cited by 9
Self-citationWei, Y., & Xu, W. (2019) · Future Cardiology · doi:10.2217/fca-2018-0062 · Cited by 9
Tegelberg, P., Tervonen, T., Knuuttila, M., Jokelainen, J., Keinänen‐Kiukaanniemi, S., Auvinen, J., & Ylöstalo, P. (2021) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13388 · Cited by 7
Ngema, M., Xulu, N. D., Ngubane, P. S., & Khathi, A. (2024) · Biomedicines · doi:10.3390/biomedicines12061372 · Cited by 10
“IFG patients have significant hepatic insulin resistance with normal skeletal muscle values and poor glucose suppression, which causes hyperglycemia during fasting due to impaired insulin secretion or reduced sensitivity of β -cells to glucose stimulation [150].”
BackgroundChaudhry, M., Kumar, M., Singhal, V., & Srinivasan, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-56933-2 · Cited by 13
Li, N., Fan, Y., Zhou, J., Maimba, O. D., Zhang, L., & Li, Q. Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s250463 · Cited by 10
Han, Y., Zhang, S., Chen, S., Zhang, J., Guo, X., & Yang, X. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820928844 · Cited by 10
Gebeyaw, E. D., & Lema, G. D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100349 · Cited by 15
Ahmadi, N., Valizadeh, M., Hadaegh, F., Mahdavi, M., Tasdighi, E., Azizi, F., & Khalili, D. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13205 · Cited by 7
Magriplis, E., Panagiotakos, D. B., Papakonstantinou, E., Mitsopoulou, A.-V., Karageorgou, D., Dimakopoulos, I., Bakogianni, I., Chourdakis, M., Micha, R., Michas, G., et al. (2021) · Public Health · doi:10.1016/j.puhe.2020.10.002 · Cited by 10
Kazek, G., Głuch‐Lutwin, M., Mordyl, B., Menaszek, E., Kubacka, M., Jurowska, A., Cież, D., Trzewik, B., Szklarzewicz, J., & Papiez, M. A. (2024) · Pharmaceuticals · doi:10.3390/ph17020229 · Cited by 6
“A much broader and still growing health problem on a global scale consists of disorders of glucose and lipid metabolism with accompanying insulin resistance, which may predispose patients to overweight, obesity, dyslipidemia, and glucose metabolism disturbances [2–4].”
BackgroundJayasvasti, I., Jayasvasti, M., Pengpid, S., Peltzer, K., & Nanthananate, P. (2021) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580211025209 · Cited by 9
Epidemiology of prediabetes mellitus among hill tribe adults in Thailand
Apidechkul, T., Chomchiei, C., Upala, P., & Tamornpark, R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271900 · Cited by 9
“[3] reported the prevalence of prediabetes, with different rates in different populations, for example, 13.”
BackgroundPrediabetes and serum insulin levels
Altemani, A. F., Alamri, A. F., Ahmed, M., Garbo, M. A., Alharbi, T. S. J., Al-Rasheed, R., Alshagraawi, S., Alzilai, I. Y. A., Alotaibi, F. A., & Al-shahrani, A. (2018) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20181494 · Cited by 8
Deviating glucose results in an international dual-center study. A root cause investigation
Bergsten, P., Bergquist, J., Cadamuro, J., Weghuber, D., Jabbour, J., Brunner, S. M., Ciba, I., Dahlbom, M., Mörwald, K., & Forslund, A. H. (2021) · Biochemia Medica · doi:10.11613/bm.2022.011001 · Cited by 7
“Several studies have investigated differences in glucose levels and IGT prevalence between countries, either by comparing data from national registers or by comparing single studies against each other (11-17).”
BackgroundIncidence of hyperglycaemic disorders in children and adolescents with obesity
Chylińska-Frątczak, A., Michalak, A., Baranowska‐Jaźwiecka, A., Mianowska, B., & Szadkowska, A. (2022) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2022.121369 · Cited by 11
“A New Zealand review of studies found a higher prevalence of IFG in Caucasians, while both IGT and a combination of IFG and IGT were more common in Asian populations [16].”
Simper, T. N., Dalton, C., Broom, D. R., Ibrahim, W., Li, L., Bankole, C., & Chen, S. (2018) · Nutrients · doi:10.3390/nu10040487 · Cited by 7
Cardiometabolic diseases: Risk factors and novel approaches for the management of risks
Rao, G. H. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95469-3.00022-x · Cited by 7
Wang, L., Xie, J., Gu, Z., Miao, X., Ma, L., Yan, S., Gong, Y., Li, C., Sun, B., & Ruan, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1514397 · Cited by 7
Harland, J. W., Hyde, N. K., Liu, Z. S.-J., Swinton, C., Spolding, B., Kotowicz, M. A., Pasco, J. A., & Holloway‐Kew, K. L. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/9926306 · Cited by 5
“Prevalence also varies by ethnicity; a meta-analysis identi fi ed that a greater proportion of Caucasians had IFG compared to Asians (43.9% Caucasian, 29.2% Asian, IFG-WHO; 58.0% Caucasian, 48.1% Asian, IFG-ADA) [6].”
InfluentialThe Tsunami of Cardiometabolic Diseases: An Overview
(2020) · Journal of Diabetes and Endocrinology Research · doi:10.47485/2693-2458/1004 · Cited by 6
Cirnigliaro, C. M., Fountaine, M. F. L., Sauer, S. J., Cross, G. T., Kirshblum, S., & Bauman, W. A. (2023) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2023.2207064 · Cited by 9
Trần, T. X. M., Kim, S., Song, H., & Park, B. (2023) · Epidemiology and Health · doi:10.4178/epih.e2023080 · Cited by 5
Webb, G. M., Sauter, K. A. D., Takahashi, D. L., Kirigiti, M. A., Bader, L., Lindsley, S. R., Blomenkamp, H., Zaro, C., Shallman, M., McGuire, C. M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.181968 · Cited by 7
“Specifically, obesity and prediabetes (and associated insulin resistance) continue to increase and are major contributors to overall morbidity and mortality (38– 42).”
BackgroundZhang, Y., Liu, S., Fan, C., Zeng, Y., Li, J., Xie, C., Xue, Y., & Guan, M. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.04.11 · Cited by 7
Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes
Potter, K. J., Bonhoure, A., Boudreau, V., Tremblay, F., Lavoie, A., Carricart, M., Senior, P. A., & RABASA-LHORET, R. P. R. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.09.025 · Cited by 6
Cuschieri, S., & Grech, S. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00563-8 · Cited by 5
Poppitt, S. D., Miles-Chan, J. L., & Silvestre, M. P. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2532559 · Cited by 4
Self-citation
Metadata
- Authors
- Yip, W., Sequeira, I., Plank, L., & Poppitt, S.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Yip, Wilson
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-11-22
- Volume
- 9
- Issue
- 11
- Pages
- 1273
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5707745
- OpenAlex
- W2769630295
- Cited by
- 177
- References
- 108
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 22 · 2023: 22 · 2022: 21 · 2021: 33 · 2020: 24 · 2019: 17 · 2018: 13
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Funders
- University of Auckland
- Fonterra Co-Operative Group
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- prediabetes, impaired fasting glucose, impaired glucose tolerance, dysglycemia, prevalence, ethnicity, type 2 diabetes risk, diagnostic thresholds
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 2, Ethnicity, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Prediabetic State, Prevalence, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.